Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas. (Q44497007)
Jump to navigation
Jump to search
scientific article published in July 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas. |
scientific article published in July 2003 |
Statements
Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas (English)
Ali Erginay
Pascale Massin
Paul Scigalla
Stéphane Richard
1 reference
1 reference
1 reference
1 reference